Voloridge Investment Management’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-42,111
Closed -$2.84M 1520
2022
Q1
$2.84M Sell
42,111
-238,952
-85% -$12.9M 0.02% 839
2021
Q4
$12.4M Buy
281,063
+218,082
+346% +$12.7M 0.07% 398
2021
Q3
$4.08M Buy
+62,981
New +$4.37M 0.03% 759
2021
Q2
Sell
-33,052
Closed -$2.25M 1682
2021
Q1
$2.25M Buy
+33,052
New +$2.6M 0.02% 787
2018
Q2
Sell
-11,762
Closed -$712K 500
2018
Q1
$712K Buy
+11,762
New +$637K 0.02% 392
2017
Q3
Sell
-45,092
Closed -$2.25M 442
2017
Q2
$2.25M Buy
+45,092
New +$2.11M 0.06% 261
2017
Q1
Sell
-67,972
Closed -$2.75M 569
2016
Q4
$2.75M Buy
+67,972
New +$2.63M 0.06% 351

Other funds holding HQY

Voloridge Investment Management's HQY Position: Q2 2022 in Review

Voloridge Investment Management sold out of HealthEquity (HQY) in Q2 2022, closing a stake of 42,111 shares — an estimated $2.84M sold.

Voloridge Investment Management first reported a position in HQY in Q4 2016 and held it in 7 quarters. The position peaked at $12.4M in Q4 2021. 307 funds tracked by Wall St. Rank hold HQY as of Q2 2022.

  • Voloridge Investment Management reported no remaining HealthEquity position as of Q2 2022 after selling out during the quarter.
  • Voloridge Investment Management sold 42,111 HealthEquity shares in Q2 2022, an estimated $2.84M.
  • Voloridge Investment Management first reported a position in HealthEquity in Q4 2016 and held it in 7 quarters.
  • Voloridge Investment Management's HealthEquity position peaked at $12.4M in Q4 2021.
  • 307 funds tracked by Wall St. Rank held HealthEquity as of Q2 2022.

Based on Voloridge Investment Management's 13F filing for Q2 2022, filed 15 Aug 2022.